Russell Investments Group
NAMS icon

Russell Investments Group’s NewAmsterdam Pharma NAMS Stock Holding History

Russell Investments Group’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
58,707
-25,678
-30% -$846K ﹤0.01% 2102
2026
Q1 		$2.7M Buy
84,385
+13,103
+18% +$427K ﹤0.01% 1703
2025
Q4 		$2.5M Buy
+71,282
New +$2.59M ﹤0.01% 1745

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Russell Investments Group's NAMS Position: Q2 2026 in Review

Russell Investments Group reduced its NewAmsterdam Pharma (NAMS) stake by 30% in Q2 2026, selling an estimated $846K and leaving 58,707 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Russell Investments Group first reported a position in NAMS in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.7M in Q1 2026. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Russell Investments Group held 58,707 shares of NewAmsterdam Pharma worth $1.99M as of Q2 2026.
  • Russell Investments Group sold 25,678 NewAmsterdam Pharma shares in Q2 2026, an estimated $846K.
  • NewAmsterdam Pharma made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2102 holding.
  • Russell Investments Group first reported a position in NewAmsterdam Pharma in Q4 2025 and has held it in 3 quarters since.
  • Russell Investments Group's NewAmsterdam Pharma position peaked at $2.7M in Q1 2026.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.